Enliven Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	124.12	100.14	75.54	110.02	130.37
Short-Term Investments	189.32	153.01	-	-	-
Cash & Short-Term Investments	313.44	253.15	75.54	110.02	130.37
Cash Growth	23.82%	235.14%	-31.35%	-15.60%	-
Prepaid Expenses	4.63	2.95	2.22	0.65	0.06
Restricted Cash	0.05	0.05	-	-	0.05
Other Current Assets	-	10	-	-	0.1
Total Current Assets	318.13	266.15	77.75	110.67	130.59
Property, Plant & Equipment	0.46	1.06	1.52	0.95	0.42
Long-Term Deferred Charges	-	0.56	3.98	1.65	-
Other Long-Term Assets	7.18	4.09	0.05	0.05	-
Total Assets	325.76	271.87	83.3	113.33	131
Accounts Payable	1.34	0.53	3.44	2.52	0.81
Accrued Expenses	14.37	14.66	4.32	2.84	0.43
Current Portion of Leases	-	0.34	0.32	0.16	0.11
Other Current Liabilities	0.2	10.36	1.64	0.23	0.14
Total Current Liabilities	15.92	25.89	9.72	5.75	1.48
Long-Term Leases	-	-	0.28	-	-
Other Long-Term Liabilities	-	0.07	0.38	0.71	0.08
Total Liabilities	15.92	25.96	10.37	6.47	1.56
Common Stock	0.05	0.04	0	0	0
Additional Paid-In Capital	553.21	400.17	6.04	2.31	0.16
Retained Earnings	-243.47	-154.45	-82.86	-45.2	-20.46
Comprehensive Income & Other	0.06	0.14	-	-	-
Total Common Equity	309.85	245.91	-76.83	-42.89	-20.3
Shareholders' Equity	309.85	245.91	72.92	106.86	129.45
Total Liabilities & Equity	325.76	271.87	83.3	113.33	131
Total Debt	-	0.34	0.6	0.16	0.11
Net Cash (Debt)	313.44	252.81	74.94	109.87	130.26
Net Cash Growth	23.98%	237.37%	-31.79%	-15.66%	-
Net Cash Per Share	6.66	7.11	23.99	14.06	26.12
Filing Date Shares Outstanding	49	41.35	12.1	11.64	4.99
Total Common Shares Outstanding	48.94	41.29	12.1	11.64	4.99
Working Capital	302.21	240.26	68.04	104.92	129.11
Book Value Per Share	6.33	5.96	-6.35	-3.68	-4.07
Tangible Book Value	309.85	245.91	-76.83	-42.89	-20.3
Tangible Book Value Per Share	6.33	5.96	-6.35	-3.68	-4.07
Machinery	1.38	1.41	1.26	0.65	0.46

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q